Department of Senological, Gynecological, Plastic and Reconstructive Surgery - Paris Professor Fabrice Lecuru - Institut Curie

Ovarian cancer

  • Ovarian cancer - Ongoing trials

    Ongoing trials

    Participation in therapeutic trials (“research protocols”) allows patients to benefit from therapeutic innovations currently being validated.

    These studies are subject to multiple validations guaranteeing their scientific interest and respect for ethics, before being offered to patients.

    The currently open surgical trials are as follows:
    - CHIPOR: benefit of CHIP (IntraPeritoneal ChemoHyperthermia) for platinum-sensitive recurrences of ovarian cancer,
    - CHRONO: surgery after 3 or 6 cycles of chemotherapy, for ovarian cancer,

    The main open drug trials are:
    - GREAT: study of the characteristics of patients with epithelial ovarian cancer based on a BRCA mutation or other genetic abnormalities
    - FIRST: addition of immunotherapy in the treatment of advanced ovarian cancer
    - OREO: re-introduction of olaparib for the treatment of a platinum-sensitive recurrence after exposure to a first PARP inhibitor,
    - BOLD: addition of immunotherapy in platinum-sensitive recurrences of ovarian cancer.

About us

After 20 years spent at the Georges Pompidou European Hospital, I preferred to continue my activity at the Institut Curie Paris.

I joined the team of Pr Fabien REYAL (Department of Senological, Gynecological and Reconstructive Surgery)

I follow my activity of Gynecological Oncological Surgery and Recourse Surgery there.

The objective remains to provide the best possible care to women with gynecological cancers,
  - By ensuring the welcome, listening and respect for the quality of life,
  - By providing access to therapeutic innovation and clinical research.
  - Consultations take place on Wednesday afternoon and Friday morning.

Make an appointment

Choose the way you want to make an appointment with Professor Lecuru's service.

Address

Institut Curie Paris

Institutional Partners

  • Chirurgie Curie Institut Curie
  • DIU DIU Européen d'Oncologie Gynécologique et Mammaire
  • SFCO Société Française de Chirurgie Oncologique
  • IMAGYN Initiative des malades atteintes de cancers gynécologiques

Scientific Partners

IMAGYN
ONCOSTREAM
YKSI Production
TMRG
© Copyright - The site is managed in partnership with the French Institute of Gynecology. It is an information and communication tool intended for the general public, patients and health professionals in particular, in accordance with the Code of medical ethics and the recommendations of the National Council of the Order of Physicians, concerning the medical ethics on the health web, adopted in a report of May 22, 2008. The information or advice contained therein is intended to inform the FRENCH public, in simplified terms, of the current state of medical science, its pathways of research and its advances. In no case may this information or advice exonerate health professionals or patients from a real consultation with an anamnesis and a clinical examination, which alone can lead to a diagnosis and a prescription.
Haut